"It's a surprising finding because several other studies have found no benefit from hydroxychloroquine, a drug originally developed to treat and prevent malaria."
The UK trial, run by the University of Oxford, enrolled more than 11,000 patients."We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalized with COVID-19," the Oxford doctors concluded.
1/7 better try again hey!
"It's a surprising finding because several other studies have...
-
- There are more pages in this discussion • 13,037 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.005(0.51%) |
Mkt cap ! $1.158B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $1.572M | 1.566M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 101675 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 54552 | 46 |
View Market Depth
| Last trade - 12.59pm 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |